vs

Side-by-side financial comparison of Bluerock Homes Trust, Inc. (BHM) and Monte Rosa Therapeutics, Inc. (GLUE). Click either name above to swap in a different company.

Bluerock Homes Trust, Inc. is the larger business by last-quarter revenue ($18.9M vs $12.8M, roughly 1.5× Monte Rosa Therapeutics, Inc.). Bluerock Homes Trust, Inc. runs the higher net margin — -50.1% vs -212.1%, a 162.0% gap on every dollar of revenue. On growth, Monte Rosa Therapeutics, Inc. posted the faster year-over-year revenue change (38.5% vs 35.9%). Monte Rosa Therapeutics, Inc. produced more free cash flow last quarter ($99.8M vs $10.4M).

Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.

Monte Rosa Therapeutics is a clinical-stage biotechnology company specializing in the discovery and development of targeted molecular glue degrader therapies. Its pipeline addresses unmet medical needs across oncology, rare genetic disorders and immunological diseases, with operations focused on advancing novel treatments for global patient populations.

BHM vs GLUE — Head-to-Head

Bigger by revenue
BHM
BHM
1.5× larger
BHM
$18.9M
$12.8M
GLUE
Growing faster (revenue YoY)
GLUE
GLUE
+2.6% gap
GLUE
38.5%
35.9%
BHM
Higher net margin
BHM
BHM
162.0% more per $
BHM
-50.1%
-212.1%
GLUE
More free cash flow
GLUE
GLUE
$89.4M more FCF
GLUE
$99.8M
$10.4M
BHM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BHM
BHM
GLUE
GLUE
Revenue
$18.9M
$12.8M
Net Profit
$-9.5M
$-27.1M
Gross Margin
Operating Margin
-48.8%
-258.3%
Net Margin
-50.1%
-212.1%
Revenue YoY
35.9%
38.5%
Net Profit YoY
-29.9%
-13.5%
EPS (diluted)
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHM
BHM
GLUE
GLUE
Q4 25
$18.9M
Q3 25
$16.6M
$12.8M
Q2 25
$16.8M
$23.2M
Q1 25
$16.4M
$84.9M
Q4 24
$13.9M
$60.6M
Q3 24
$12.7M
Q2 24
$12.5M
Q1 24
$11.2M
Net Profit
BHM
BHM
GLUE
GLUE
Q4 25
$-9.5M
Q3 25
$-10.0M
$-27.1M
Q2 25
$-5.8M
$-12.3M
Q1 25
$-7.3M
$46.9M
Q4 24
$-7.3M
$13.4M
Q3 24
$3.5M
Q2 24
$-5.2M
Q1 24
$-3.2M
Operating Margin
BHM
BHM
GLUE
GLUE
Q4 25
-48.8%
Q3 25
-57.6%
-258.3%
Q2 25
-30.9%
-67.1%
Q1 25
-42.6%
51.9%
Q4 24
-52.8%
21.4%
Q3 24
27.9%
Q2 24
-41.3%
Q1 24
-28.4%
Net Margin
BHM
BHM
GLUE
GLUE
Q4 25
-50.1%
Q3 25
-60.0%
-212.1%
Q2 25
-34.7%
-53.0%
Q1 25
-44.7%
55.2%
Q4 24
-52.8%
22.2%
Q3 24
27.9%
Q2 24
-41.3%
Q1 24
-28.4%
EPS (diluted)
BHM
BHM
GLUE
GLUE
Q4 25
$-0.75
Q3 25
$-0.94
Q2 25
$-0.66
Q1 25
$-0.67
Q4 24
$-0.65
Q3 24
$0.24
Q2 24
$-0.42
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHM
BHM
GLUE
GLUE
Cash + ST InvestmentsLiquidity on hand
$169.6M
$208.3M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$128.7M
$245.8M
Total Assets
$1.2B
$459.8M
Debt / EquityLower = less leverage
3.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHM
BHM
GLUE
GLUE
Q4 25
$169.6M
Q3 25
$2.1M
$208.3M
Q2 25
$4.2M
$69.4M
Q1 25
$3.0M
$78.5M
Q4 24
$115.2M
$224.3M
Q3 24
$155.1M
Q2 24
$116.0M
Q1 24
$92.3M
Total Debt
BHM
BHM
GLUE
GLUE
Q4 25
$428.4M
Q3 25
$415.9M
Q2 25
$338.6M
Q1 25
$336.5M
Q4 24
$373.8M
Q3 24
$122.5M
Q2 24
$119.7M
Q1 24
$120.2M
Stockholders' Equity
BHM
BHM
GLUE
GLUE
Q4 25
$128.7M
Q3 25
$131.7M
$245.8M
Q2 25
$135.3M
$268.1M
Q1 25
$137.1M
$275.2M
Q4 24
$139.1M
$222.9M
Q3 24
$142.9M
Q2 24
$142.5M
Q1 24
$144.5M
Total Assets
BHM
BHM
GLUE
GLUE
Q4 25
$1.2B
Q3 25
$222.1M
$459.8M
Q2 25
$220.3M
$359.6M
Q1 25
$186.2M
$393.2M
Q4 24
$967.0M
$438.7M
Q3 24
$800.8M
Q2 24
$756.2M
Q1 24
$727.4M
Debt / Equity
BHM
BHM
GLUE
GLUE
Q4 25
3.33×
Q3 25
3.16×
Q2 25
2.50×
Q1 25
2.45×
Q4 24
2.69×
Q3 24
0.86×
Q2 24
0.84×
Q1 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHM
BHM
GLUE
GLUE
Operating Cash FlowLast quarter
$27.8M
$100.4M
Free Cash FlowOCF − Capex
$10.4M
$99.8M
FCF MarginFCF / Revenue
55.0%
781.5%
Capex IntensityCapex / Revenue
91.8%
5.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.0M
$145.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHM
BHM
GLUE
GLUE
Q4 25
$27.8M
Q3 25
$13.4M
$100.4M
Q2 25
$13.9M
$-34.7M
Q1 25
$951.0K
$-45.5M
Q4 24
$9.1M
$128.9M
Q3 24
$1.7M
Q2 24
$1.3M
Q1 24
$1.1M
Free Cash Flow
BHM
BHM
GLUE
GLUE
Q4 25
$10.4M
Q3 25
$8.7M
$99.8M
Q2 25
$8.8M
$-36.4M
Q1 25
$-2.9M
$-47.1M
Q4 24
$-253.0K
$128.7M
Q3 24
$-601.0K
Q2 24
$-654.0K
Q1 24
$-630.0K
FCF Margin
BHM
BHM
GLUE
GLUE
Q4 25
55.0%
Q3 25
52.4%
781.5%
Q2 25
52.2%
-157.0%
Q1 25
-17.6%
-55.4%
Q4 24
-1.8%
212.3%
Q3 24
-4.7%
Q2 24
-5.2%
Q1 24
-5.6%
Capex Intensity
BHM
BHM
GLUE
GLUE
Q4 25
91.8%
Q3 25
28.5%
5.1%
Q2 25
30.3%
7.3%
Q1 25
23.4%
1.9%
Q4 24
66.9%
0.3%
Q3 24
18.0%
Q2 24
15.3%
Q1 24
15.5%
Cash Conversion
BHM
BHM
GLUE
GLUE
Q4 25
Q3 25
Q2 25
Q1 25
-0.97×
Q4 24
9.59×
Q3 24
0.47×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BHM
BHM

Residential Communities Segment$11.4M61%
Scattered Single Family Homes Segment$7.5M39%

GLUE
GLUE

Segment breakdown not available.

Related Comparisons